Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
26 Apr 24
8-K
Teladoc Health Reports First Quarter 2024 Results
25 Apr 24
8-K
Departure of Directors or Certain Officers
12 Apr 24
ARS
2023 FY
Annual report to shareholders
9 Apr 24
DEFA14A
Additional proxy soliciting materials
9 Apr 24
DEF 14A
Definitive proxy
9 Apr 24
8-K
Teladoc Health Board of Directors Announces Leadership Transition
5 Apr 24
10-K
2023 FY
Annual report
23 Feb 24
8-K
Teladoc Health Reports Fourth Quarter and Full Year 2023 Results
20 Feb 24
8-K
Departure of Directors or Certain Officers
14 Nov 23
10-Q
2023 Q3
Quarterly report
27 Oct 23
8-K
Teladoc Health Reports Third Quarter 2023 Results
24 Oct 23
8-K
Teladoc Health Appoints Leading Healthcare and Hospitals Executive
20 Sep 23
S-8
Registration of securities for employees
28 Jul 23
10-Q
2023 Q2
Quarterly report
28 Jul 23
8-K
Teladoc Health Reports Second Quarter 2023 Results
25 Jul 23
S-8 POS
Registration of securities for employees (post-effective amendment)
30 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
30 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
30 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
30 May 23
S-8
Registration of securities for employees
30 May 23
SD
Conflict minerals disclosure
30 May 23
8-K
Departure of Directors or Certain Officers
30 May 23
DEFA14A
Additional proxy soliciting materials
15 May 23
10-Q
2023 Q1
Quarterly report
2 May 23
8-K
Teladoc Health Reports First Quarter 2023 Results
26 Apr 23
ARS
2022 FY
Annual report to shareholders
11 Apr 23
DEFA14A
Additional proxy soliciting materials
11 Apr 23
DEF 14A
Definitive proxy
11 Apr 23
S-8
Registration of securities for employees
1 Mar 23
10-K
2022 FY
Annual report
1 Mar 23
8-K
Teladoc Health Reports Fourth Quarter and Full Year 2022 Results
22 Feb 23
8-K
Cost Associated with Exit or Disposal Activities
18 Jan 23
8-K
Results of Operations and Financial Condition
9 Jan 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
8-K
Teladoc Health Names Laizer Kornwasser as President, Enterprise Growth & Global Markets
28 Oct 22
8-K
Teladoc Health Reports Third-Quarter 2022 Results
26 Oct 22
UPLOAD
Letter from SEC
6 Oct 22
CORRESP
Correspondence with SEC
3 Oct 22
UPLOAD
Letter from SEC
20 Sep 22
Latest ownership filings
4
Laizer Kornwasser
2 May 24
4
Michael Willem Waters
2 May 24
4
Vidya Raman-Tangella
2 May 24
144
Notice of proposed sale of securities
2 May 24
144
Notice of proposed sale of securities
2 May 24
144
Notice of proposed sale of securities
2 May 24
144
Notice of proposed sale of securities
29 Apr 24
144
Notice of proposed sale of securities
19 Apr 24
4
Daniel Trencher
17 Apr 24
144
Notice of proposed sale of securities
17 Apr 24
4
Mala Murthy
8 Apr 24
4
Nikolaos P. Nanis
3 Apr 24
144
Notice of proposed sale of securities
2 Apr 24
4
Arnnon Geshuri
26 Mar 24
144
Notice of proposed sale of securities
25 Mar 24
4
Stephany Verstraete
20 Mar 24
4
Mala Murthy
20 Mar 24
4
JASON N GOREVIC
20 Mar 24
4
Nikolaos P. Nanis
20 Mar 24
4
Daniel Trencher
20 Mar 24
4
Andrew Turitz
20 Mar 24
4
Arnnon Geshuri
20 Mar 24
4
Richard J Napolitano
20 Mar 24
4
Laizer Kornwasser
20 Mar 24
4
Vidya Raman-Tangella
20 Mar 24
4
Michael Willem Waters
20 Mar 24
4
Adam C Vandervoort
20 Mar 24
4
Daniel Trencher
18 Mar 24
144
Notice of proposed sale of securities
18 Mar 24
4
Andrew Turitz
6 Mar 24
4
Laizer Kornwasser
5 Mar 24
4
Richard J Napolitano
5 Mar 24
4
Michael Willem Waters
5 Mar 24
4
Stephany Verstraete
5 Mar 24
4
Adam C Vandervoort
5 Mar 24
4
JASON N GOREVIC
5 Mar 24
4
Nikolaos P. Nanis
5 Mar 24
4
Vidya Raman-Tangella
5 Mar 24
4
Andrew Turitz
5 Mar 24
4
Daniel Trencher
5 Mar 24